Shop
Description
Vaginax Vaginal Pessary is a medication used to treat vaginal infections, particularly those caused by yeast (fungal) and certain bacteria. The specific formulation of Vaginax Vaginal Pessary may vary, but it commonly contains active ingredients such as clotrimazole, metronidazole, and miconazole.
**Primary Uses:**
– Treatment of vaginal yeast infections (candidiasis).
– Management of bacterial vaginosis.
– Addressing mixed infections involving both yeast and bacteria.
**Drug Class or Type:**
– Antifungal and antibacterial agent.
**General Mechanism of Action:**
– Clotrimazole and miconazole are antifungal agents that inhibit the growth of yeast by disrupting their cell membranes.
– Metronidazole is an antibiotic that targets anaerobic bacteria, disrupting their DNA and inhibiting their growth.
**Common Forms:**
– Vaginal pessaries (suppositories) containing the active ingredients.
**Dosage Instructions:**
– Typically, one pessary is inserted deep into the vagina at bedtime.
– The usual treatment duration is 3 to 7 consecutive nights, depending on the specific infection and medical advice.
– It’s important to follow the dosage instructions provided by a healthcare professional or as indicated on the product packaging.
**Side Effects, Contraindications, or Interactions:**
– Common side effects may include vaginal itching, burning, redness, or abdominal discomfort.
– Rare side effects can include nausea or allergic reactions.
– Avoid using the pessary during menstruation.
– Refrain from consuming alcohol during treatment and for at least 48 hours after completing the course, as metronidazole can cause a disulfiram-like reaction.
– Consult a healthcare provider before use if pregnant, breastfeeding, or if you have a history of liver disease or seizures.
– Inform your doctor if you are taking other medications, as interactions may occur.
Always consult a healthcare professional before starting any new medication to ensure it is appropriate for your specific health needs.
Reviews
There are no reviews yet.